DOSAGE RECOMMENDATION FACILITATED BY ARTIFICIAL INTELLIGENCE

    公开(公告)号:US20220241501A1

    公开(公告)日:2022-08-04

    申请号:US17162065

    申请日:2021-01-29

    Abstract: Disclosed herein are techniques related to glucose level management without carbohydrate counting. The techniques may involve obtaining contextual information for a meal, predicting amounts of glucose to be absorbed into a bloodstream of the patient over a duration of time due to consumption of the meal based on the contextual information for the meal, determining one or more amounts of insulin to counteract effects of the predicted amounts of glucose, and affecting insulin therapy based on outputting information indicative of the determined one or more amounts of insulin.

    AUTOMATED PROJECTION MODE SWITCHING FOR GLUCOSE LEVELS

    公开(公告)号:US20220105269A1

    公开(公告)日:2022-04-07

    申请号:US17481745

    申请日:2021-09-22

    Abstract: In general, techniques are described for automated projection mode for switching glucose levels. A device for assisting in therapy delivery comprising a memory and a processor configured to perform the techniques. The memory may store first projected levels of glucose in a patient over a first time frame. The processor may determine an occurrence of a projection event that alters how projected levels of glucose are to be output, and automatically determine, based on the projection event, a second time frame that differs from the first time frame, The processor may also obtain a current glucose level of the patient, obtain, based on the current glucose level, second projected levels of glucose in the patient over the second time frame, and output the second projected levels of glucose for the second time frame.

    AUTOMATIC DISABLING OF ALERTS FOR DIABETIC CONDITIONS

    公开(公告)号:US20220104761A1

    公开(公告)日:2022-04-07

    申请号:US17481757

    申请日:2021-09-22

    Abstract: In general, techniques are described for automatic disablement of alerts for diabetic conditions. A device including a memory and a processor may be configured to perform the techniques. The memory may store alert data. The processor may obtain projected levels of glucose in a patient over a time frame, and determine whether the projected levels of glucose leave a prescribed range. The processor may generate, when the projected levels of glucose in the patient leave the prescribed range during the time frame and based on the alert data, a graphical alert indicating that the projected levels of glucose will leave the prescribed range. The processor may further determine that a maintenance event alters the projected levels of glucose, and disable, without user input and based on the determination that the maintenance event alters the projected levels of glucose, the graphical alert for a temporary period of time.

    PREDICTION BASED DELIVERING OR GUIDING OF THERAPY FOR DIABETES

    公开(公告)号:US20210060246A1

    公开(公告)日:2021-03-04

    申请号:US17004951

    申请日:2020-08-27

    Abstract: An example system for therapy delivery includes one or more processors configured to in response to a prediction indicating that the meal event is to occur, output instructions to an insulin delivery device to deliver a partial therapy dosage, to a device to notify the patient to use the insulin delivery device to take the partial therapy dosage, or to the insulin delivery device to prepare the partial therapy dosage prior to the meal event occurring, and in response to a determination indicating that the meal event is occurring (e.g., based on movement characteristics of a patient arm), output instructions to the insulin delivery device to deliver a remaining therapy dosage, to the device to notify the patient to use the insulin delivery device to take the remaining therapy dosage, or to the insulin delivery device to prepare the remaining therapy dosage.

Patent Agency Ranking